Dai­ichi Sankyo set­tles its car­dio drug law­suit with Es­pe­ri­on, which will get $125M mile­stone pay­ment

Dai­ichi Sankyo Eu­rope and Es­pe­ri­on Ther­a­peu­tics have agreed to a $125 mil­lion change to their col­lab­o­ra­tion agree­ment, set­tling a le­gal dis­pute …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.